{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T17:28:46Z","timestamp":1771349326970,"version":"3.50.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To investigate a new method for controlling the direction of subretinal hematoma migration during tissue plasminogen activator (tPA) treatment by selecting the tPA injection site.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Retrospective, interventional case series. An artificial retinal detachment was created by subretinal injection of tPA into the healthy lower retina of 18 patients, temporal to the fovea. The posterior pole of the detached retina was continuous with the subretinal hematoma, allowing tPA to access the lesion. After tPA infusion, the vitreous cavity was filled with SF\n                      <jats:sub>6<\/jats:sub>\n                      gas, and the surgery was concluded.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Foveal subretinal hematoma size decreased from 610 \u00b1 489\n                      <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>\n                      m preoperatively to 68 \u00b1 134\n                      <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>\n                      m 1 month postoperatively. In all the cases, the subretinal hematoma moved downward from the temporal side of the fovea. Postoperatively, the mean difference in the angle between the tPA injection site (centered on the fovea centralis) and the hematoma's final position was 19\u00b0 \u00b1 14\u00b0, and the hematomas migrated toward the artificial retinal detachment site.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>It is feasible to manipulate the migration of subretinal hematoma toward an artificial retinal detachment created by subretinal tPA injection outside the lesion. This approach may minimize macular compromise in lesions superior to the macula.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004701","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:02:39Z","timestamp":1761224559000},"page":"548-556","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A NOVEL TECHNIQUE FOR SUBRETINAL HEMATOMA MIGRATION"],"prefix":"10.1097","volume":"46","author":[{"given":"Erina","family":"Goda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8372-5418","authenticated-orcid":false,"given":"Yuki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Suzuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260217","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/archopht.1991.01080050139046","article-title":"Fibrin directs early retinal damage after experimental subretinal hemorrhage","volume":"109","author":"Toth","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"R2-20260217","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/0002-9394(82)90301-4","article-title":"Experimental subretinal hemorrhage in rabbits","volume":"94","author":"Glatt","year":"1982","journal-title":"Am J Ophthalmol"},{"key":"R3-20260217","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0002-9394(14)72107-5","article-title":"Variations in the clinical course of submacular hemorrhage","volume":"122","author":"Berrocal","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"R4-20260217","doi-asserted-by":"crossref","first-page":"e000394","DOI":"10.1136\/bmjophth-2019-000394","article-title":"Outcomes of pars plana vitrectomy with subretinal tissue plasminogen activator injection and pneumatic displacement of fovea-involving submacular haemorrhage","volume":"5","author":"Wilkins","year":"2020","journal-title":"BMJ Open Ophthalmol"},{"key":"R5-20260217","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.survophthal.2015.04.004","article-title":"Submacular hemorrhage in neovascular age-related macular degeneration: a synthesis of the literature","volume":"61","author":"Stanescu-Segall","year":"2016","journal-title":"Surv Ophthalmol"},{"key":"R6-20260217","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0002-9394(00)00734-0","article-title":"Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration","volume":"131","author":"Haupert","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R7-20260217","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.ajo.2014.02.007","article-title":"Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration","volume":"157","author":"Chang","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R8-20260217","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archopht.1990.01070040111042","article-title":"Retinal toxicity of recombinant tissue plasminogen activator in the rabbit","volume":"108","author":"Johnson","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"R9-20260217","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00417-017-3648-3","article-title":"Massive subretinal and subretinal pigment epithelial hemorrhage displacement with perfluorocarbon liquid using a two-step vitrectomy technique","volume":"255","author":"Fleissig","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R10-20260217","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/IAE.0000000000003104","article-title":"Subretinal injection under perfluorocarbon liquids to avoid foveal dehiscence","volume":"43","author":"Steel","year":"2023","journal-title":"Retina"},{"key":"R11-20260217","first-page":"98","article-title":"Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage\/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement","volume":"103","author":"Thompson","year":"2005","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R12-20260217","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/IAE.0b013e3180439bc9","article-title":"Analysis of forces acting upon submacular hemorrhage in pneumatic displacement","volume":"27","author":"Stopa","year":"2007","journal-title":"Retina"},{"key":"R13-20260217","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ophtha.2014.07.027","article-title":"Displacement of submacular hemorrhages in age-related macular degeneration with subretinal tissue plasminogen activator and air","volume":"122","author":"Kadonosono","year":"2015","journal-title":"Ophthalmology"},{"key":"R14-20260217","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/eye.2016.65","article-title":"Vitrectomy with subretinal tissue plasminogen activator and ranibizumab for submacular haemorrhages secondary to age-related macular degeneration: retrospective case series of 45 consecutive cases","volume":"30","author":"Gonz\u00e1lez-L\u00f3pez","year":"2016","journal-title":"Eye (Lond)"},{"key":"R15-20260217","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.4103\/ijo.IJO_1987_22","article-title":"Real-world outcomes and complications of different surgical approaches for significant submacular haemorrhages","volume":"71","author":"Boral","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"R16-20260217","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12886-024-03660-x","article-title":"Combined treatment of submacular hemorrhage with low-dose subretinal recombinant tissue plasminogen activator and intravitreal conbercept","volume":"24","author":"Ma","year":"2024","journal-title":"BMC Ophthalmol"},{"key":"R17-20260217","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/IAE.0b013e31806e60db","article-title":"A 40 degrees gaze down position for pneumatic displacement of submacular hemorrhage: clinical application and results","volume":"28","author":"Lincoff","year":"2008","journal-title":"Retina"},{"key":"R18-20260217","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/IAE.0b013e3181dd6d8a","article-title":"Prospective one-year study of ranibizumab for predominantly hemorrhagic choroidal neovascular lesions in age-related macular degeneration","volume":"30","author":"Chang","year":"2010","journal-title":"Retina"},{"key":"R19-20260217","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/eye.2009.271","article-title":"Ranibizumab monotherapy for sub-foveal haemorrhage secondary to choroidal neovascularisation in age-related macular degeneration","volume":"24","author":"McKibbin","year":"2010","journal-title":"Eye (Lond)"},{"key":"R20-20260217","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.ophtha.2023.04.014","article-title":"Surgery, tissue plasminogen activator, antiangiogenic agents, and age-related macular degeneration study: a randomized controlled trial for submacular hemorrhage secondary to age-related macular degeneration","volume":"130","author":"Gabrielle","year":"2023","journal-title":"Ophthalmology"},{"key":"R21-20260217","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13063-025-08727-8","article-title":"Vitrectomy, subretinal tissue plasminogen activator and intravitreal gas for submacular haemorrhage secondary to exudative age-related macular degeneration (TIGER): update to study protocol and addition of a statistical analysis plan and health economic analysis plan for a randomised controlled surgical trial","volume":"26","author":"Lee","year":"2025","journal-title":"Trials"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004701","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T17:00:13Z","timestamp":1771347613000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004701"}},"subtitle":["Directing the Lesion Toward Artificial Retinal Detachment"],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004701","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}